Lv1
34 积分 2026-01-06 加入
In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity
19天前
已完结
Clickable Universal Tumor-Antigen Equipping Strategy for Remedial Chimeric Antigen Receptor T Cells to Destroy Solid Tumors
19天前
已完结
NIR-II Nanomedicine Engineered CAR-NK Cells for Precision Navigation and Potentiating Lung Cancer Immunotherapy by Remodeling Tumor Microenvironment
1个月前
已完结
NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors
1个月前
已完结
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer
1个月前
已完结
CAR-T-drug conjugate against solid tumor
2个月前
已完结
Discovery of Novel and Potent Dual PARP1/ERK Inhibitors as a Promising Strategy for Cancer Therapy
2个月前
已完结
ROS-Activated Peptide-Based Prodrug for Chemoselective Covalent Targeting in Cancer Cells
2个月前
已完结
T-Cell “Rejuvenation” Nanovaccine: Enhancing Immunological Memory and Antitumor Responses through Telomere Extension
3个月前
已完结
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
4个月前
已完结
皖公网安备34019202002308
